T. Rowe Price Associates’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21.7M | Sell |
1,566,213
-2,821,148
| -64% | -$44.9M | ﹤0.01% | 1015 |
|
|
2025
Q4 | $71.3M | Buy |
4,387,361
+3,299,635
| +303% | +$53.9M | 0.01% | 709 |
|
|
2025
Q3 | $16.3M | Buy |
1,087,726
+965,524
| +790% | +$11.8M | ﹤0.01% | 1101 |
|
|
2025
Q2 | $1.42M | Buy |
122,202
+22,740
| +23% | +$207K | ﹤0.01% | 1809 |
|
|
2025
Q1 | $740K | Buy |
99,462
+5,570
| +6% | +$42.8K | ﹤0.01% | 2095 |
|
|
2024
Q4 | $563K | Sell |
93,892
-65,931
| -41% | -$364K | ﹤0.01% | 2241 |
|
|
2024
Q3 | $819K | Buy |
159,823
+1,016
| +0.6% | +$4.43K | ﹤0.01% | 2048 |
|
|
2024
Q2 | $575K | Buy |
158,807
+3,578
| +2% | +$11.4K | ﹤0.01% | 2135 |
|
|
2024
Q1 | $499K | Sell |
155,229
-137,655
| -47% | -$533K | ﹤0.01% | 2212 |
|
|
2023
Q4 | $1.44M | Sell |
292,884
-15,867
| -5% | -$72.4K | ﹤0.01% | 1697 |
|
|
2023
Q3 | $1.68M | Sell |
308,751
-1,238,541
| -80% | -$8.19M | ﹤0.01% | 1540 |
|
|
2023
Q2 | $10.4M | Sell |
1,547,292
-211,657
| -12% | -$1.57M | ﹤0.01% | 1077 |
|
|
2023
Q1 | $15.5M | Sell |
1,758,949
-79,517
| -4% | -$701K | ﹤0.01% | 977 |
|
|
2022
Q4 | $14M | Sell |
1,838,466
-53,618
| -3% | -$417K | ﹤0.01% | 993 |
|
|
2022
Q3 | $13.5M | Sell |
1,892,084
-10,291,811
| -84% | -$96.9M | ﹤0.01% | 1011 |
|
|
2022
Q2 | $98.6M | Sell |
12,183,895
-232,472
| -2% | -$2.04M | 0.01% | 670 |
|
|
2022
Q1 | $172M | Sell |
12,416,367
-870,346
| -7% | -$13.7M | 0.02% | 571 |
|
|
2021
Q4 | $373M | Buy |
13,286,713
+1,840,491
| +16% | +$56.4M | 0.03% | 405 |
|
|
2021
Q3 | $389M | Buy |
11,446,222
+479,331
| +4% | +$17.3M | 0.04% | 392 |
|
|
2021
Q2 | $448M | Buy |
10,966,891
+1,342,666
| +14% | +$52.2M | 0.04% | 361 |
|
|
2021
Q1 | $387M | Buy |
9,624,225
+3,669,449
| +62% | +$199M | 0.04% | 383 |
|
|
2020
Q4 | $352M | Buy |
5,954,776
+2,114,378
| +55% | +$109M | 0.04% | 399 |
|
|
2020
Q3 | $187M | Buy |
3,840,398
+1,117,025
| +41% | +$46.9M | 0.02% | 500 |
|
|
2020
Q2 | $132M | Sell |
2,723,373
-580,147
| -18% | -$21.2M | 0.02% | 565 |
|
|
2020
Q1 | $91.8M | Buy |
3,303,520
+1,101,522
| +50% | +$30.7M | 0.01% | 595 |
|
|
2019
Q4 | $65.9M | Buy |
2,201,998
+1,495,074
| +211% | +$42.9M | 0.01% | 805 |
|
|
2019
Q3 | $21.8M | Sell |
706,924
-193,076
| -21% | -$7.88M | ﹤0.01% | 1118 |
|
|
2019
Q2 | $43.5M | Buy |
+900,000
| New | +$39.9M | 0.01% | 935 |
|
Other funds holding ADPT
VCM
VPM
